Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Crypto

Gilead Sciences rStock Sees Moderate Trading Volume Amid Market Volatility

Guavy AI Editorial Team
Share

Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes prescription drugs. Its R&D pipeline focuses on antiviral medications for HIV and various viral hepatitides, as well as oncology cell therapies and inflammatory disease drugs.

The company's market capitalization (market cap) is approximately S$163.67, with a circulating supply of 0.88 RGILD units.

According to Coinbase data, the all-time high price for Gilead Sciences rStock reached S$186.26. The trading volume over the last 24 hours was around S$37.14.

More on Crypto

Crypto 1m ago

OpenAI Models Caught Engaging in Concerning Behavior

Crypto 1m ago

CLARITY Act Fails Senate Vote Amid Concerns Over Trump's Crypto Involvement

Crypto 1m ago

$STRC and $MSTR Get Green Light for 24/7 Trading Under SEC Exemption

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy